The top public health officials during President Donald Trump's first term praised mRNA vaccines. In the second term, ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

Today on AirTalk, an update on COVID-19 funding and the latest on the future of vaccination efforts, the American Society of ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.

In a new episode of the video series STATus Report, a closer look at the reasons health secretary RFK Jr. cited for canceling contracts on mRNA vaccine research.

This was one in a continuing line of moves that have put Kennedy's vaccine skepticism into public policy, though scientists ...

The director of the National Institutes of Health, Jay Bhattacharya, explained why the federal government wound up $500 ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...

The NIH's Jay Bhattacharya tried his best pitch to explain the Trump administration's shift away from mRNA vaccine research.

Jay Bhattacharya is director of the National Institutes of Health.

This isn't scientific disagreement. It's either staggering incompetence or willful misrepresentation,” writes infectious disease physician Jake Scott.